Mobilization and Outcomes After Venous Closure
Start Date
11/24/2025
Completion Date
8/1/2026
Summary
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
Detailed Description
The study is a single-arm, prospective, multi-center, observational, real-world registry of venous access site closures utilizing MYNX CONTROL™ VENOUS VCD 6F-12F following endovascular procedures. The study will enroll approximately 300 subjects in approximately 15 study sites in the United States.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
MYNX CONTROLTM VENOUS Vascular Closure Device
Conditions
Locations
South Denver Cardiology
Littleton, Colorado 80210
United States
KC Heart and Rhythm Institute
Overland Park, Kansas 66211
United States
North Carolina Heart & Vascular Research, LLC
Raleigh, North Carolina 27607
United States